ANDA 62240, held by Chartwell Rx. Cloxacillin Sodium.
As of Nov 16, 2026, ANDA 62240 (Cloxacillin Sodium), held by Chartwell Rx, was first approved by FDA on Jun 5, 1980, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 5, 1980 | Original application | Approved | None posted |
| Cloxacillin SodiumEQ 250MG BASE · capsule;oral | Cloxacillin Sodium | Discontinued |
| Cloxacillin SodiumEQ 500MG BASE · capsule;oral | Cloxacillin Sodium | Discontinued |
| Jul 7, 2000 | Supplement 7Manufacturing | Approved | None posted |
| Dec 10, 1997 | Supplement 6Manufacturing | Approved | None posted |
| Aug 27, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Jan 13, 1994 | Supplement 1Labeling | Approved | None posted |
| Jun 29, 1993 | Supplement 2Labeling | Approved | None posted |
| Jun 5, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters